Circular RNA Cdr1as inhibits proliferation and delays injury-induced regeneration of the intestinal epithelium.

Autor: Chung HK; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Xiao L; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA., Han N; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Chen J; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Yao V; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Cairns CM; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Raufman B; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Rao JN; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA., Turner DJ; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA., Kozar R; Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland, USA., Gorospe M; Laboratory of Genetics and Genomics, National Institute on Aging-IRP, NIH, Baltimore, Maryland, USA., Wang JY; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA.; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Publikováno v: JCI insight [JCI Insight] 2024 Jan 16; Vol. 9 (4). Date of Electronic Publication: 2024 Jan 16.

The capsular polysaccharides of Pasteurella multocida serotypes B and E: Structural, genetic and serological comparisons.

Autor: Michael FS; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada., Cairns CM; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada., Fleming P; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada., Vinogradov EV; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada., Boyce JD; Infection and Immunity Program, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Wellington Rd, Melbourne 3800, Australia., Harper M; Infection and Immunity Program, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Wellington Rd, Melbourne 3800, Australia., Cox AD; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada.

Publikováno v: Glycobiology [Glycobiology] 2021 Apr 01; Vol. 31 (3), pp. 307-314.

Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficile Lipoteichoic Acid.

Autor: Cairns CM; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., van Faassen H; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., St Michael F; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Aubry A; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Henry KA; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Rossotti MA; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Logan SM; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Hussack G; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Gisch N; Division of Bioanalytical Chemistry, Priority Research Area Infections, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany., Hogendorf WFJ; Department of Chemistry, University of Copenhagen, 2100 Copenhagen, Denmark., Pedersen CM; Department of Chemistry, University of Copenhagen, 2100 Copenhagen, Denmark., Cox AD; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada.

Publikováno v: ACS chemical biology [ACS Chem Biol] 2020 Apr 17; Vol. 15 (4), pp. 1050-1058. Date of Electronic Publication: 2020 Apr 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides.

Autor: St Michael F; Vaccine Program, Human Health Therapeutics Portfolio, National Research Council, 100, Sussex Drive, Ottawa, ON, K1A 0R6, Canada., Cairns CM, Filion AL, Biolchi A, Brunelli B, Giuliani M, Richards JC, Cox AD

Publikováno v: Glycoconjugate journal [Glycoconj J] 2014 Jan; Vol. 31 (1), pp. 25-39. Date of Electronic Publication: 2013 Sep 07.